In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...
Generation LNP Advancements enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic ...
Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback